Gsa Capital Partners LLP Aptevo Therapeutics Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.48 - $17.49 $88,458 - $238,755
-13,651 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$15.01 - $22.16 $204,901 - $302,506
13,651 New
13,651 $211,000
Q4 2020

Feb 03, 2021
SELL
$6.21 - $48.36 $251,579 - $1.96 Million
-40,512 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$7.21 - $9.37 $292,091 - $379,597
40,512 New
40,512 $308,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email